AR002005A1 - Fragmentos de anticuerpos monoclonales que tienen actividad inmuno supresora, procedimiento para su preparacion, composicion farmaceutica que loscontiene y metodo para la supresion de la respuesta inmune. - Google Patents

Fragmentos de anticuerpos monoclonales que tienen actividad inmuno supresora, procedimiento para su preparacion, composicion farmaceutica que loscontiene y metodo para la supresion de la respuesta inmune.

Info

Publication number
AR002005A1
AR002005A1 ARP950100448A AR10044895A AR002005A1 AR 002005 A1 AR002005 A1 AR 002005A1 AR P950100448 A ARP950100448 A AR P950100448A AR 10044895 A AR10044895 A AR 10044895A AR 002005 A1 AR002005 A1 AR 002005A1
Authority
AR
Argentina
Prior art keywords
fragments
suppression
procedure
preparation
pharmaceutical composition
Prior art date
Application number
ARP950100448A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR002005A1 publication Critical patent/AR002005A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP950100448A 1994-12-07 1995-12-05 Fragmentos de anticuerpos monoclonales que tienen actividad inmuno supresora, procedimiento para su preparacion, composicion farmaceutica que loscontiene y metodo para la supresion de la respuesta inmune. AR002005A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07

Publications (1)

Publication Number Publication Date
AR002005A1 true AR002005A1 (es) 1998-01-07

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100448A AR002005A1 (es) 1994-12-07 1995-12-05 Fragmentos de anticuerpos monoclonales que tienen actividad inmuno supresora, procedimiento para su preparacion, composicion farmaceutica que loscontiene y metodo para la supresion de la respuesta inmune.

Country Status (19)

Country Link
EP (1) EP0787151A1 (cs)
JP (1) JP2001506122A (cs)
CN (1) CN1168679A (cs)
AR (1) AR002005A1 (cs)
AU (1) AU4256096A (cs)
BR (1) BR9509902A (cs)
CA (1) CA2206471A1 (cs)
CO (1) CO4480041A1 (cs)
CZ (1) CZ172497A3 (cs)
FI (1) FI972430L (cs)
HU (1) HUT77342A (cs)
IL (1) IL116228A0 (cs)
MA (1) MA23739A1 (cs)
NO (1) NO972522L (cs)
PE (1) PE52996A1 (cs)
PL (1) PL320610A1 (cs)
TR (1) TR199501542A2 (cs)
WO (1) WO1996017874A1 (cs)
ZA (1) ZA9510195B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
AU5588099A (en) * 1998-08-28 2000-03-21 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156060B1 (en) * 2000-05-12 2007-06-27 GPC Biotech AG Human peptides/proteins causing or leading to the killing of cells including lymphoid tumor cells
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
US6894149B2 (en) 2001-10-11 2005-05-17 Protein Design Labs, Inc. Anti-HLA-DA antibodies and the methods of using thereof
US7262278B2 (en) 2001-10-15 2007-08-28 Kirin Beer Kabushiki Kaisha Anti-HLA-DR antibody
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
CA2794499A1 (en) * 2010-04-01 2011-10-06 Immumomedics, Inc. Antibody-based depletion of antigen-presenting cells and dendritic cells
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
DE69028713T3 (de) * 1989-12-27 2004-05-13 Centocor, Inc. Schimäre immunoglobuline für cd4-rezeptoren
ES2196002T3 (es) * 1991-07-25 2003-12-16 Idec Pharma Corp Anticuerpos recombinantes para terapia humana.

Also Published As

Publication number Publication date
BR9509902A (pt) 1997-10-21
AU4256096A (en) 1996-06-26
JP2001506122A (ja) 2001-05-15
CA2206471A1 (en) 1996-06-13
TR199501542A2 (tr) 1996-07-21
PL320610A1 (en) 1997-10-13
EP0787151A1 (en) 1997-08-06
CN1168679A (zh) 1997-12-24
NO972522L (no) 1997-08-06
IL116228A0 (en) 1996-03-31
FI972430A7 (fi) 1997-06-06
FI972430A0 (fi) 1997-06-06
NO972522D0 (no) 1997-06-03
ZA9510195B (en) 1996-06-07
WO1996017874A1 (en) 1996-06-13
CZ172497A3 (en) 1997-10-15
MX9704225A (es) 1997-09-30
HUT77342A (hu) 1998-03-30
FI972430L (fi) 1997-06-06
PE52996A1 (es) 1996-12-12
MA23739A1 (fr) 1996-07-01
CO4480041A1 (es) 1997-07-09

Similar Documents

Publication Publication Date Title
ES2191016T3 (es) Anticuerpos monoclonales neutralizantes humanos para el virus respiratorio sincitial.
MX9400166A (es) Microesferas de proteina vegetal, hidrolizada, modificada y metodos para su preparacion y su uso.
GB2301366A (en) Antibodies against E-selectin
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
NO20081124L (no) Anti-CD 3 antistoff-formuleringer
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
AR010752A1 (es) COMPUESTOS QUE SE ENLAZAN A Y ACTIVAN UN RECEPTOR DE LA TROMBOPOYETINA; COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN, SU USO PARA LA PREPARACION DE MEDICAMENTOS, Y PROCESO PARA PREPARAR DICHA COMPOSICIoN.
AR002005A1 (es) Fragmentos de anticuerpos monoclonales que tienen actividad inmuno supresora, procedimiento para su preparacion, composicion farmaceutica que loscontiene y metodo para la supresion de la respuesta inmune.
SE8904004L (sv) Anti-tumoersubstans och foerfarande foer framstaellning av densamma
PT845998E (pt) Medicamentos para imunoterapia contendo anticorpos que reconhecem de forma especifica o antigenio mhcii de um paciente a ser tratado
AU2002223462A1 (en) Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28
EP0552296A4 (en) Mouse monoclonal antibodies
DK0969873T3 (da) Multiple carbonhydratholdige glycopeptid-antigener, vaccine indeholdende dem og anvendelse deraf
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
AU625171B2 (en) Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses
PT948319E (pt) Celulas encapsuladas produtoras de anticorpos
ITMI912745A0 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
IT8320920A0 (it) Derivati di cicloalcani, procedimento per la loro preparazione e composizioni che licontengono.
DK102589D0 (da) Antigen, der genkendes af mca 16-88
MX9202912A (es) Nuevos anticuerpos monoclonales dirigidos contra el virus de la inmunosuficiencia humana y proceso para su preparacion.
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.